Omega-3 fatty acids
EPA and DHA supplementation.
Notify me when meaningful evidence changes.
0
Insufficient evidence · Stable
No history yet
Current assessment
Large trials have produced mixed results. Cardiovascular benefit appears to depend on formulation, dose, and baseline risk.
- Regulatory status
- Supplement
- Availability
- Widely available
- Category
- Accessible
- Human studies tracked
- 0
Evidence breakdown
Human evidence
0
Animal evidence
0
Mechanistic
0
Safety
50
What changed
Evidence events affecting this intervention
No published evidence events yet
Evidence timeline
Every recorded score change
No score history yet
Major human studies
No human studies tracked yet
Animal and mechanistic evidence
No preclinical studies tracked yet